

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.66865677 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.66865677 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 7.32839073 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.32839073 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.85880954 |
| 6 | exogenous drug catabolic process (GO:0042738) | 6.54277780 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.50134951 |
| 8 | epoxygenase P450 pathway (GO:0019373) | 6.41508445 |
| 9 | omega-hydroxylase P450 pathway (GO:0097267) | 6.26882365 |
| 10 | tryptophan catabolic process (GO:0006569) | 6.12784627 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 6.12784627 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 6.12784627 |
| 13 | oxidative demethylation (GO:0070989) | 6.04579460 |
| 14 | kynurenine metabolic process (GO:0070189) | 6.00865090 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.92378321 |
| 16 | glyoxylate metabolic process (GO:0046487) | 5.81700233 |
| 17 | tryptophan metabolic process (GO:0006568) | 5.76889006 |
| 18 | high-density lipoprotein particle remodeling (GO:0034375) | 5.73565288 |
| 19 | negative regulation of fibrinolysis (GO:0051918) | 5.68270219 |
| 20 | urea metabolic process (GO:0019627) | 5.65564522 |
| 21 | urea cycle (GO:0000050) | 5.65564522 |
| 22 | alpha-linolenic acid metabolic process (GO:0036109) | 5.63254945 |
| 23 | regulation of fibrinolysis (GO:0051917) | 5.46761491 |
| 24 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.40948788 |
| 25 | protein carboxylation (GO:0018214) | 5.40948788 |
| 26 | sulfur amino acid catabolic process (GO:0000098) | 5.35230442 |
| 27 | cysteine metabolic process (GO:0006534) | 5.34244820 |
| 28 | complement activation, alternative pathway (GO:0006957) | 5.29723512 |
| 29 | regulation of protein activation cascade (GO:2000257) | 5.23491393 |
| 30 | nitrogen cycle metabolic process (GO:0071941) | 5.20032556 |
| 31 | serine family amino acid catabolic process (GO:0009071) | 5.15219266 |
| 32 | drug metabolic process (GO:0017144) | 5.12826624 |
| 33 | bile acid metabolic process (GO:0008206) | 5.11089163 |
| 34 | regulation of cholesterol esterification (GO:0010872) | 5.03836755 |
| 35 | reverse cholesterol transport (GO:0043691) | 4.98634392 |
| 36 | aromatic amino acid family metabolic process (GO:0009072) | 4.98233751 |
| 37 | phenylpropanoid metabolic process (GO:0009698) | 4.97690235 |
| 38 | regulation of triglyceride catabolic process (GO:0010896) | 4.88858852 |
| 39 | plasma lipoprotein particle remodeling (GO:0034369) | 4.88269027 |
| 40 | protein-lipid complex remodeling (GO:0034368) | 4.88269027 |
| 41 | macromolecular complex remodeling (GO:0034367) | 4.88269027 |
| 42 | tyrosine metabolic process (GO:0006570) | 4.87270380 |
| 43 | regulation of complement activation (GO:0030449) | 4.87245583 |
| 44 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.79379340 |
| 45 | homocysteine metabolic process (GO:0050667) | 4.73024348 |
| 46 | phospholipid efflux (GO:0033700) | 4.70486941 |
| 47 | negative regulation of sterol transport (GO:0032372) | 4.69540030 |
| 48 | negative regulation of cholesterol transport (GO:0032375) | 4.69540030 |
| 49 | acylglycerol homeostasis (GO:0055090) | 4.68549114 |
| 50 | triglyceride homeostasis (GO:0070328) | 4.68549114 |
| 51 | alpha-amino acid catabolic process (GO:1901606) | 4.64707229 |
| 52 | amino-acid betaine metabolic process (GO:0006577) | 4.59774859 |
| 53 | cellular ketone body metabolic process (GO:0046950) | 4.56918432 |
| 54 | lysine catabolic process (GO:0006554) | 4.54344879 |
| 55 | lysine metabolic process (GO:0006553) | 4.54344879 |
| 56 | plasma lipoprotein particle clearance (GO:0034381) | 4.47771196 |
| 57 | alkaloid metabolic process (GO:0009820) | 4.47663150 |
| 58 | glycine metabolic process (GO:0006544) | 4.47114385 |
| 59 | bile acid and bile salt transport (GO:0015721) | 4.43864480 |
| 60 | indolalkylamine metabolic process (GO:0006586) | 4.34154712 |
| 61 | coenzyme catabolic process (GO:0009109) | 4.31448838 |
| 62 | cholesterol efflux (GO:0033344) | 4.31031550 |
| 63 | imidazole-containing compound metabolic process (GO:0052803) | 4.30386268 |
| 64 | cellular glucuronidation (GO:0052695) | 4.29295290 |
| 65 | cellular amino acid catabolic process (GO:0009063) | 4.26977613 |
| 66 | amine catabolic process (GO:0009310) | 4.25520472 |
| 67 | cellular biogenic amine catabolic process (GO:0042402) | 4.25520472 |
| 68 | glutamate metabolic process (GO:0006536) | 4.21235774 |
| 69 | ethanol metabolic process (GO:0006067) | 4.18142680 |
| 70 | serine family amino acid metabolic process (GO:0009069) | 4.18052813 |
| 71 | benzene-containing compound metabolic process (GO:0042537) | 4.15450268 |
| 72 | aldehyde catabolic process (GO:0046185) | 4.10717915 |
| 73 | low-density lipoprotein particle remodeling (GO:0034374) | 4.10522069 |
| 74 | plasma lipoprotein particle assembly (GO:0034377) | 4.07802888 |
| 75 | ethanol oxidation (GO:0006069) | 4.07241790 |
| 76 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.04240940 |
| 77 | serine family amino acid biosynthetic process (GO:0009070) | 4.03946798 |
| 78 | arginine metabolic process (GO:0006525) | 4.03165438 |
| 79 | fibrinolysis (GO:0042730) | 4.02605135 |
| 80 | cellular modified amino acid catabolic process (GO:0042219) | 4.01835984 |
| 81 | ketone body metabolic process (GO:1902224) | 3.95594087 |
| 82 | drug catabolic process (GO:0042737) | 3.95461976 |
| 83 | negative regulation of protein activation cascade (GO:2000258) | 3.92547129 |
| 84 | blood coagulation, intrinsic pathway (GO:0007597) | 3.89204919 |
| 85 | S-adenosylmethionine metabolic process (GO:0046500) | 3.85891985 |
| 86 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.84836881 |
| 87 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.84836881 |
| 88 | negative regulation of lipase activity (GO:0060192) | 3.83717173 |
| 89 | glucuronate metabolic process (GO:0019585) | 3.80882695 |
| 90 | uronic acid metabolic process (GO:0006063) | 3.80882695 |
| 91 | positive regulation of lipid catabolic process (GO:0050996) | 3.80128901 |
| 92 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.79656910 |
| 93 | cofactor catabolic process (GO:0051187) | 3.77758670 |
| 94 | cholesterol homeostasis (GO:0042632) | 3.77241936 |
| 95 | phospholipid homeostasis (GO:0055091) | 3.75382336 |
| 96 | flavonoid metabolic process (GO:0009812) | 3.75351116 |
| 97 | carboxylic acid catabolic process (GO:0046395) | 3.74261558 |
| 98 | organic acid catabolic process (GO:0016054) | 3.74261558 |
| 99 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.72831905 |
| 100 | complement activation, classical pathway (GO:0006958) | 3.72389508 |
| 101 | arginine catabolic process (GO:0006527) | 3.71732558 |
| 102 | regulation of bile acid biosynthetic process (GO:0070857) | 3.71270488 |
| 103 | protein activation cascade (GO:0072376) | 3.71253227 |
| 104 | negative regulation of complement activation (GO:0045916) | 3.71179547 |
| 105 | complement activation (GO:0006956) | 3.71099622 |
| 106 | sterol homeostasis (GO:0055092) | 3.70950690 |
| 107 | plasma lipoprotein particle organization (GO:0071827) | 3.69866460 |
| 108 | short-chain fatty acid metabolic process (GO:0046459) | 3.68475581 |
| 109 | protein-lipid complex assembly (GO:0065005) | 3.65561434 |
| 110 | acetyl-CoA metabolic process (GO:0006084) | 3.60352651 |
| 111 | NAD biosynthetic process (GO:0009435) | 3.59646148 |
| 112 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.56359965 |
| 113 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.56359965 |
| 114 | xenobiotic catabolic process (GO:0042178) | 3.55328899 |
| 115 | regulation of cholesterol homeostasis (GO:2000188) | 3.54759012 |
| 116 | amino acid salvage (GO:0043102) | 3.53371959 |
| 117 | L-methionine salvage (GO:0071267) | 3.53371959 |
| 118 | L-methionine biosynthetic process (GO:0071265) | 3.53371959 |
| 119 | regulation of plasminogen activation (GO:0010755) | 3.39668758 |
| 120 | drug transmembrane transport (GO:0006855) | 3.36467928 |
| 121 | nucleobase catabolic process (GO:0046113) | 3.34650693 |
| 122 | steroid catabolic process (GO:0006706) | 3.34256434 |
| 123 | negative regulation of blood coagulation (GO:0030195) | 3.25716161 |
| 124 | negative regulation of hemostasis (GO:1900047) | 3.25716161 |
| 125 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.22714841 |
| 126 | xenobiotic metabolic process (GO:0006805) | 3.22066184 |
| 127 | heme transport (GO:0015886) | 3.17503932 |
| 128 | indole-containing compound metabolic process (GO:0042430) | 3.14815922 |
| 129 | cellular response to sterol (GO:0036315) | 3.06063302 |
| 130 | peptidyl-glutamic acid modification (GO:0018200) | 3.05896521 |
| 131 | negative regulation of coagulation (GO:0050819) | 3.03944465 |
| 132 | negative regulation of wound healing (GO:0061045) | 2.98824002 |
| 133 | regulation of humoral immune response (GO:0002920) | 2.94458546 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.43314735 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.21270359 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.06422316 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.54041439 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.28866481 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.18503360 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.86252849 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.04499439 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.04142636 |
| 10 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.10495221 |
| 11 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.82929838 |
| 12 | VDR_22108803_ChIP-Seq_LS180_Human | 2.77532210 |
| 13 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.67464478 |
| 14 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.57294776 |
| 15 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.51653122 |
| 16 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.49030956 |
| 17 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.18993566 |
| 18 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.11189982 |
| 19 | ER_23166858_ChIP-Seq_MCF-7_Human | 2.10900923 |
| 20 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.05839574 |
| 21 | P300_19829295_ChIP-Seq_ESCs_Human | 2.02980515 |
| 22 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.01790080 |
| 23 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 2.00019155 |
| 24 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9710930 |
| 25 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.95353841 |
| 26 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.94622964 |
| 27 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.93009633 |
| 28 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.86560540 |
| 29 | FUS_26573619_Chip-Seq_HEK293_Human | 1.77096453 |
| 30 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.76473763 |
| 31 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.76360712 |
| 32 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.72320629 |
| 33 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.72185688 |
| 34 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.70174789 |
| 35 | EWS_26573619_Chip-Seq_HEK293_Human | 1.68860929 |
| 36 | STAT3_23295773_ChIP-Seq_U87_Human | 1.68369852 |
| 37 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.67534071 |
| 38 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.66572352 |
| 39 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.66572352 |
| 40 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.65074977 |
| 41 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.64357110 |
| 42 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.62529420 |
| 43 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.61717463 |
| 44 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.60524658 |
| 45 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.58279321 |
| 46 | TCF4_23295773_ChIP-Seq_U87_Human | 1.57155356 |
| 47 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.52649451 |
| 48 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.51769663 |
| 49 | AR_25329375_ChIP-Seq_VCAP_Human | 1.47774499 |
| 50 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.46683734 |
| 51 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.44119469 |
| 52 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.43309474 |
| 53 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.43097890 |
| 54 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.42104611 |
| 55 | GATA1_22025678_ChIP-Seq_K562_Human | 1.41838387 |
| 56 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.41322512 |
| 57 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40977847 |
| 58 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.39916896 |
| 59 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.39916896 |
| 60 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.39405523 |
| 61 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.38227597 |
| 62 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.36414295 |
| 63 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.35825427 |
| 64 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.34476226 |
| 65 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.34322622 |
| 66 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.32250256 |
| 67 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.31376033 |
| 68 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.31325318 |
| 69 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.30420738 |
| 70 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.30030233 |
| 71 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.28274210 |
| 72 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.27956687 |
| 73 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.25666770 |
| 74 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.23282236 |
| 75 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.22453479 |
| 76 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.22411776 |
| 77 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.20734220 |
| 78 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.19082117 |
| 79 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.18625973 |
| 80 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.18196944 |
| 81 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.18167813 |
| 82 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.17677320 |
| 83 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.16118253 |
| 84 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.16118253 |
| 85 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.15790502 |
| 86 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.15414591 |
| 87 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.12471629 |
| 88 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.12262542 |
| 89 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.11973711 |
| 90 | * POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.11749302 |
| 91 | * TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11749302 |
| 92 | TP53_16413492_ChIP-PET_HCT116_Human | 1.11510235 |
| 93 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.08940474 |
| 94 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.08710641 |
| 95 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.08299255 |
| 96 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.07389972 |
| 97 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.07102099 |
| 98 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.06590176 |
| 99 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.04312642 |
| 100 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03923540 |
| 101 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.03888378 |
| 102 | ETV1_20927104_ChIP-Seq_GIST48_Human | 1.03417037 |
| 103 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.02858551 |
| 104 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.01805733 |
| 105 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.01678687 |
| 106 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.96699153 |
| 107 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.95927689 |
| 108 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.91100624 |
| 109 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.86706897 |
| 110 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.85301567 |
| 111 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.81841513 |
| 112 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.81546594 |
| 113 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.81165232 |
| 114 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.81099287 |
| 115 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.79651915 |
| 116 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.79215349 |
| 117 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.76387348 |
| 118 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.75343711 |
| 119 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.74274774 |
| 120 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.72351602 |
| 121 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.71555450 |
| 122 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.70637517 |
| 123 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.68774810 |
| 124 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.67019290 |
| 125 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.66768788 |
| 126 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66284477 |
| 127 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.64466631 |
| 128 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.64466631 |
| 129 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.62801164 |
| 130 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.62271757 |
| 131 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.62099948 |
| 132 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.61888345 |
| 133 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.61639222 |
| 134 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.61154476 |
| 135 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.60547832 |
| 136 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57873308 |
| 137 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.56403626 |
| 138 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.52548151 |
| 139 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52472057 |
| 140 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.52359326 |
| 141 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.51625857 |
| 142 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.51458485 |
| 143 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.50808167 |
| 144 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.50706766 |
| 145 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.50224535 |
| 146 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.49436813 |
| 147 | CBP_21632823_ChIP-Seq_H3396_Human | 0.48848890 |
| 148 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.48305966 |
| 149 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.48127188 |
| 150 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.47009948 |
| 151 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.45761764 |
| 152 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.45216057 |
| 153 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.44723132 |
| 154 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.43554095 |
| 155 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.42783534 |
| 156 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.42599373 |
| 157 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.42223893 |
| 158 | GATA1_19941826_ChIP-Seq_K562_Human | 0.41983532 |
| 159 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.41563333 |
| 160 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.41443335 |
| 161 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.41203315 |
| 162 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.40974919 |
| 163 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.40812579 |
| 164 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.40456979 |
| 165 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.40205659 |
| 166 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.40157564 |
| 167 | GATA2_19941826_ChIP-Seq_K562_Human | 0.39952226 |
| 168 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.38504595 |
| 169 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.37560029 |
| 170 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.37547036 |
| 171 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.36979741 |
| 172 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.36499623 |
| 173 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.36137084 |
| 174 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.36034958 |
| 175 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.35669324 |
| 176 | NCOR_22424771_ChIP-Seq_293T_Human | 0.35648068 |
| 177 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.35385707 |
| 178 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.34507717 |
| 179 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.33253066 |
| 180 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.33053257 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.41429028 |
| 2 | MP0005360_urolithiasis | 7.58591588 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.46041101 |
| 4 | MP0005365_abnormal_bile_salt | 6.14688413 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.21718961 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.26185737 |
| 7 | MP0003252_abnormal_bile_duct | 3.89748099 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.60737258 |
| 9 | MP0009840_abnormal_foam_cell | 3.35742979 |
| 10 | MP0005083_abnormal_biliary_tract | 3.04812654 |
| 11 | MP0003195_calcinosis | 2.83026740 |
| 12 | MP0005332_abnormal_amino_acid | 2.73917063 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.58685006 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.32187786 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.15824092 |
| 16 | * MP0000609_abnormal_liver_physiology | 2.12880924 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.09237104 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 1.93529356 |
| 19 | MP0003868_abnormal_feces_composition | 1.91205869 |
| 20 | MP0005551_abnormal_eye_electrophysiolog | 1.84133879 |
| 21 | MP0005319_abnormal_enzyme/_coenzyme | 1.81880375 |
| 22 | MP0000569_abnormal_digit_pigmentation | 1.70847642 |
| 23 | MP0001764_abnormal_homeostasis | 1.66949930 |
| 24 | MP0009697_abnormal_copulation | 1.65698802 |
| 25 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.57401352 |
| 26 | MP0000372_irregular_coat_pigmentation | 1.56794253 |
| 27 | MP0006292_abnormal_olfactory_placode | 1.51523713 |
| 28 | MP0005451_abnormal_body_composition | 1.46252233 |
| 29 | MP0003011_delayed_dark_adaptation | 1.40428700 |
| 30 | MP0001968_abnormal_touch/_nociception | 1.37978528 |
| 31 | MP0002736_abnormal_nociception_after | 1.37631991 |
| 32 | MP0005646_abnormal_pituitary_gland | 1.35345398 |
| 33 | MP0003656_abnormal_erythrocyte_physiolo | 1.29782533 |
| 34 | MP0003186_abnormal_redox_activity | 1.27490026 |
| 35 | MP0001501_abnormal_sleep_pattern | 1.27186077 |
| 36 | MP0001986_abnormal_taste_sensitivity | 1.26237025 |
| 37 | MP0010386_abnormal_urinary_bladder | 1.22399636 |
| 38 | MP0009643_abnormal_urine_homeostasis | 1.22171037 |
| 39 | MP0009745_abnormal_behavioral_response | 1.20582390 |
| 40 | MP0003880_abnormal_central_pattern | 1.19872560 |
| 41 | MP0000598_abnormal_liver_morphology | 1.17113897 |
| 42 | MP0005647_abnormal_sex_gland | 1.13101048 |
| 43 | MP0003705_abnormal_hypodermis_morpholog | 1.11660686 |
| 44 | MP0002938_white_spotting | 1.10336733 |
| 45 | MP0002102_abnormal_ear_morphology | 1.09976801 |
| 46 | MP0000604_amyloidosis | 1.09274610 |
| 47 | MP0009764_decreased_sensitivity_to | 1.06820516 |
| 48 | MP0003646_muscle_fatigue | 1.05435835 |
| 49 | MP0009046_muscle_twitch | 1.03507609 |
| 50 | MP0009763_increased_sensitivity_to | 1.03121601 |
| 51 | MP0006276_abnormal_autonomic_nervous | 1.01070989 |
| 52 | MP0002254_reproductive_system_inflammat | 1.00073596 |
| 53 | MP0008877_abnormal_DNA_methylation | 0.99287261 |
| 54 | MP0005187_abnormal_penis_morphology | 0.99019847 |
| 55 | MP0010368_abnormal_lymphatic_system | 0.98035248 |
| 56 | MP0005253_abnormal_eye_physiology | 0.97601881 |
| 57 | MP0004043_abnormal_pH_regulation | 0.93888200 |
| 58 | MP0002282_abnormal_trachea_morphology | 0.93750302 |
| 59 | MP0005645_abnormal_hypothalamus_physiol | 0.93733405 |
| 60 | MP0005636_abnormal_mineral_homeostasis | 0.91527097 |
| 61 | MP0008469_abnormal_protein_level | 0.88174201 |
| 62 | MP0005408_hypopigmentation | 0.87135885 |
| 63 | MP0009642_abnormal_blood_homeostasis | 0.86687604 |
| 64 | MP0001485_abnormal_pinna_reflex | 0.85188223 |
| 65 | MP0003136_yellow_coat_color | 0.83463899 |
| 66 | MP0006036_abnormal_mitochondrial_physio | 0.82458657 |
| 67 | MP0002638_abnormal_pupillary_reflex | 0.82291665 |
| 68 | MP0002272_abnormal_nervous_system | 0.81952461 |
| 69 | MP0002234_abnormal_pharynx_morphology | 0.80912345 |
| 70 | MP0001486_abnormal_startle_reflex | 0.80799032 |
| 71 | MP0005376_homeostasis/metabolism_phenot | 0.79630167 |
| 72 | MP0009765_abnormal_xenobiotic_induced | 0.79248308 |
| 73 | MP0005410_abnormal_fertilization | 0.77888109 |
| 74 | MP0002078_abnormal_glucose_homeostasis | 0.77174077 |
| 75 | MP0004924_abnormal_behavior | 0.76936836 |
| 76 | MP0005386_behavior/neurological_phenoty | 0.76936836 |
| 77 | MP0001984_abnormal_olfaction | 0.76861558 |
| 78 | MP0002876_abnormal_thyroid_physiology | 0.76602065 |
| 79 | MP0003950_abnormal_plasma_membrane | 0.74778148 |
| 80 | MP0005670_abnormal_white_adipose | 0.73764724 |
| 81 | MP0000427_abnormal_hair_cycle | 0.72458809 |
| 82 | MP0005084_abnormal_gallbladder_morpholo | 0.72439692 |
| 83 | MP0001529_abnormal_vocalization | 0.72107232 |
| 84 | MP0006072_abnormal_retinal_apoptosis | 0.70886554 |
| 85 | MP0001324_abnormal_eye_pigmentation | 0.70828117 |
| 86 | MP0002971_abnormal_brown_adipose | 0.70231777 |
| 87 | MP0005220_abnormal_exocrine_pancreas | 0.69351718 |
| 88 | MP0001661_extended_life_span | 0.68354078 |
| 89 | MP0005334_abnormal_fat_pad | 0.67680122 |
| 90 | MP0004147_increased_porphyrin_level | 0.67063945 |
| 91 | MP0004130_abnormal_muscle_cell | 0.66974361 |
| 92 | MP0003690_abnormal_glial_cell | 0.66859339 |
| 93 | MP0004142_abnormal_muscle_tone | 0.66670692 |
| 94 | MP0002735_abnormal_chemical_nociception | 0.66314728 |
| 95 | MP0009053_abnormal_anal_canal | 0.65934251 |
| 96 | MP0005535_abnormal_body_temperature | 0.65431659 |
| 97 | MP0000371_diluted_coat_color | 0.64498225 |
| 98 | MP0004215_abnormal_myocardial_fiber | 0.64017819 |
| 99 | MP0005266_abnormal_metabolism | 0.63990467 |
| 100 | MP0002557_abnormal_social/conspecific_i | 0.63873967 |
| 101 | MP0002572_abnormal_emotion/affect_behav | 0.62466672 |
| 102 | MP0000639_abnormal_adrenal_gland | 0.61774042 |
| 103 | MP0003329_amyloid_beta_deposits | 0.61625866 |
| 104 | MP0002064_seizures | 0.59869830 |
| 105 | MP0005195_abnormal_posterior_eye | 0.58642235 |
| 106 | MP0000631_abnormal_neuroendocrine_gland | 0.58564827 |
| 107 | MP0001756_abnormal_urination | 0.56972616 |
| 108 | MP0005174_abnormal_tail_pigmentation | 0.56633498 |
| 109 | MP0004133_heterotaxia | 0.56467038 |
| 110 | MP0005448_abnormal_energy_balance | 0.54943923 |
| 111 | MP0003698_abnormal_male_reproductive | 0.54927185 |
| 112 | MP0002067_abnormal_sensory_capabilities | 0.54727367 |
| 113 | MP0002229_neurodegeneration | 0.53883745 |
| 114 | MP0005464_abnormal_platelet_physiology | 0.53782165 |
| 115 | MP0006035_abnormal_mitochondrial_morpho | 0.53280982 |
| 116 | MP0002822_catalepsy | 0.50681685 |
| 117 | MP0005395_other_phenotype | 0.48840561 |
| 118 | MP0003718_maternal_effect | 0.48586237 |
| 119 | MP0003638_abnormal_response/metabolism_ | 0.46447370 |
| 120 | MP0008874_decreased_physiological_sensi | 0.46413113 |
| 121 | MP0008873_increased_physiological_sensi | 0.45654405 |
| 122 | MP0002136_abnormal_kidney_physiology | 0.43818592 |
| 123 | MP0002837_dystrophic_cardiac_calcinosis | 0.43807169 |
| 124 | MP0002928_abnormal_bile_duct | 0.43116608 |
| 125 | MP0004782_abnormal_surfactant_physiolog | 0.42459975 |
| 126 | MP0003436_decreased_susceptibility_to | 0.42258398 |
| 127 | MP0008872_abnormal_physiological_respon | 0.41289183 |
| 128 | MP0003075_altered_response_to | 0.41021132 |
| 129 | MP0005248_abnormal_Harderian_gland | 0.40469814 |
| 130 | MP0003953_abnormal_hormone_level | 0.40447742 |
| 131 | MP0003724_increased_susceptibility_to | 0.40302925 |
| 132 | MP0009672_abnormal_birth_weight | 0.37312414 |
| 133 | MP0005166_decreased_susceptibility_to | 0.37028548 |
| 134 | MP0005666_abnormal_adipose_tissue | 0.34201143 |
| 135 | MP0000249_abnormal_blood_vessel | 0.33455123 |
| 136 | MP0004883_abnormal_blood_vessel | 0.33325466 |
| 137 | MP0004381_abnormal_hair_follicle | 0.33169929 |
| 138 | MP0006082_CNS_inflammation | 0.32786206 |
| 139 | MP0001243_abnormal_dermal_layer | 0.32220560 |
| 140 | MP0000579_abnormal_nail_morphology | 0.32155895 |
| 141 | MP0002796_impaired_skin_barrier | 0.31822197 |
| 142 | MP0009115_abnormal_fat_cell | 0.30912356 |
| 143 | MP0000230_abnormal_systemic_arterial | 0.30845547 |
| 144 | MP0002168_other_aberrant_phenotype | 0.29207805 |
| 145 | MP0002970_abnormal_white_adipose | 0.29201572 |
| 146 | MP0001853_heart_inflammation | 0.28631595 |
| 147 | MP0001881_abnormal_mammary_gland | 0.28438927 |
| 148 | MP0009384_cardiac_valve_regurgitation | 0.27420177 |
| 149 | MP0002132_abnormal_respiratory_system | 0.26899480 |
| 150 | * MP0001845_abnormal_inflammatory_respons | 0.25442091 |
| 151 | MP0005164_abnormal_response_to | 0.25351713 |
| 152 | MP0002090_abnormal_vision | 0.24083123 |
| 153 | MP0005167_abnormal_blood-brain_barrier | 0.23587179 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.53755381 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.49538278 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.31574358 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.66234186 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.64509868 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.54767076 |
| 7 | Xanthomatosis (HP:0000991) | 6.28899158 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.68752969 |
| 9 | Complement deficiency (HP:0004431) | 5.20841399 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.88867023 |
| 11 | Joint hemorrhage (HP:0005261) | 4.85781339 |
| 12 | Hyperammonemia (HP:0001987) | 4.62624846 |
| 13 | Abnormality of the common coagulation pathway (HP:0010990) | 4.47463919 |
| 14 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.46936396 |
| 15 | Hyperglycinemia (HP:0002154) | 4.45758408 |
| 16 | Epidermoid cyst (HP:0200040) | 4.45095147 |
| 17 | Abnormality of methionine metabolism (HP:0010901) | 4.28225304 |
| 18 | Ketosis (HP:0001946) | 4.26081527 |
| 19 | Hypoalphalipoproteinemia (HP:0003233) | 4.26030816 |
| 20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.23432701 |
| 21 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.10394942 |
| 22 | Fat malabsorption (HP:0002630) | 4.10125804 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.09874695 |
| 24 | Hypoglycemic coma (HP:0001325) | 3.92803174 |
| 25 | Abnormality of glycine metabolism (HP:0010895) | 3.92335308 |
| 26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.92335308 |
| 27 | Hyperglycinuria (HP:0003108) | 3.91192316 |
| 28 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.82746324 |
| 29 | Abnormality of the intrinsic pathway (HP:0010989) | 3.81754680 |
| 30 | Fair hair (HP:0002286) | 3.81260751 |
| 31 | Abnormality of complement system (HP:0005339) | 3.80271245 |
| 32 | Conjugated hyperbilirubinemia (HP:0002908) | 3.71075821 |
| 33 | Hypercholesterolemia (HP:0003124) | 3.65357385 |
| 34 | Hyperbilirubinemia (HP:0002904) | 3.39007938 |
| 35 | Hyperventilation (HP:0002883) | 3.36054630 |
| 36 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.35348627 |
| 37 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.34681161 |
| 38 | Delayed CNS myelination (HP:0002188) | 3.13863246 |
| 39 | Pancreatic cysts (HP:0001737) | 3.11488277 |
| 40 | Steatorrhea (HP:0002570) | 3.09377450 |
| 41 | Abnormality of serum amino acid levels (HP:0003112) | 3.07524474 |
| 42 | Abnormality of nucleobase metabolism (HP:0010932) | 3.07156655 |
| 43 | Ketoacidosis (HP:0001993) | 3.01694541 |
| 44 | Hypochromic microcytic anemia (HP:0004840) | 3.00655417 |
| 45 | Hepatocellular carcinoma (HP:0001402) | 2.99497219 |
| 46 | Spontaneous abortion (HP:0005268) | 2.98774294 |
| 47 | Myocardial infarction (HP:0001658) | 2.87800076 |
| 48 | Pancreatic fibrosis (HP:0100732) | 2.84268977 |
| 49 | Generalized hypopigmentation of hair (HP:0011358) | 2.83952264 |
| 50 | Abnormality of the renal cortex (HP:0011035) | 2.83113838 |
| 51 | True hermaphroditism (HP:0010459) | 2.82441117 |
| 52 | Metabolic acidosis (HP:0001942) | 2.77694399 |
| 53 | Skin nodule (HP:0200036) | 2.74337220 |
| 54 | Abnormal biliary tract physiology (HP:0012439) | 2.72330910 |
| 55 | Bile duct proliferation (HP:0001408) | 2.72330910 |
| 56 | Congenital stationary night blindness (HP:0007642) | 2.69808528 |
| 57 | Abnormality of purine metabolism (HP:0004352) | 2.69361820 |
| 58 | Systemic lupus erythematosus (HP:0002725) | 2.63238266 |
| 59 | Dicarboxylic aciduria (HP:0003215) | 2.62271355 |
| 60 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.62271355 |
| 61 | Lethargy (HP:0001254) | 2.61867428 |
| 62 | Vascular calcification (HP:0004934) | 2.59319583 |
| 63 | Gaze-evoked nystagmus (HP:0000640) | 2.59055614 |
| 64 | Chronic hepatic failure (HP:0100626) | 2.57384047 |
| 65 | Acanthocytosis (HP:0001927) | 2.55638337 |
| 66 | Hypoglycemic seizures (HP:0002173) | 2.51015067 |
| 67 | Abnormal gallbladder morphology (HP:0012437) | 2.51007442 |
| 68 | Glomerulonephritis (HP:0000099) | 2.49266938 |
| 69 | Hypothermia (HP:0002045) | 2.48574077 |
| 70 | Cholelithiasis (HP:0001081) | 2.44615051 |
| 71 | Spastic diplegia (HP:0001264) | 2.44203906 |
| 72 | Cerebral edema (HP:0002181) | 2.43405103 |
| 73 | Attenuation of retinal blood vessels (HP:0007843) | 2.42361940 |
| 74 | Mitral stenosis (HP:0001718) | 2.39682431 |
| 75 | Gout (HP:0001997) | 2.38802200 |
| 76 | Abnormal gallbladder physiology (HP:0012438) | 2.38298532 |
| 77 | Cholecystitis (HP:0001082) | 2.38298532 |
| 78 | Irritability (HP:0000737) | 2.34837274 |
| 79 | Neonatal onset (HP:0003623) | 2.31476695 |
| 80 | Abnormality of midbrain morphology (HP:0002418) | 2.30665304 |
| 81 | Molar tooth sign on MRI (HP:0002419) | 2.30665304 |
| 82 | Cardiovascular calcification (HP:0011915) | 2.29917137 |
| 83 | Amyloidosis (HP:0011034) | 2.29726635 |
| 84 | Malnutrition (HP:0004395) | 2.25788155 |
| 85 | Esophageal varix (HP:0002040) | 2.23644060 |
| 86 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.22540220 |
| 87 | Gingival bleeding (HP:0000225) | 2.20847828 |
| 88 | Arthropathy (HP:0003040) | 2.20546327 |
| 89 | Menorrhagia (HP:0000132) | 2.20466511 |
| 90 | Thyroid-stimulating hormone excess (HP:0002925) | 2.19480798 |
| 91 | Abnormality of alanine metabolism (HP:0010916) | 2.17105615 |
| 92 | Hyperalaninemia (HP:0003348) | 2.17105615 |
| 93 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.17105615 |
| 94 | Abnormality of urine glucose concentration (HP:0011016) | 2.14016091 |
| 95 | Glycosuria (HP:0003076) | 2.14016091 |
| 96 | Pancreatitis (HP:0001733) | 2.13707718 |
| 97 | Nephronophthisis (HP:0000090) | 2.13600954 |
| 98 | Late onset (HP:0003584) | 2.11533727 |
| 99 | Progressive cerebellar ataxia (HP:0002073) | 2.11298879 |
| 100 | Sensorimotor neuropathy (HP:0007141) | 2.10173874 |
| 101 | Reduced antithrombin III activity (HP:0001976) | 2.10095089 |
| 102 | Thrombophlebitis (HP:0004418) | 2.09407673 |
| 103 | Enlarged kidneys (HP:0000105) | 2.09231297 |
| 104 | Congenital sensorineural hearing impairment (HP:0008527) | 2.09137941 |
| 105 | Brushfield spots (HP:0001088) | 2.08888445 |
| 106 | Generalized aminoaciduria (HP:0002909) | 2.07463453 |
| 107 | Cystic liver disease (HP:0006706) | 2.06849555 |
| 108 | Vomiting (HP:0002013) | 2.06217304 |
| 109 | Abnormality of the renal medulla (HP:0100957) | 2.06026882 |
| 110 | Poikilocytosis (HP:0004447) | 2.05069547 |
| 111 | Opisthotonus (HP:0002179) | 2.04552235 |
| 112 | Blue irides (HP:0000635) | 2.03843666 |
| 113 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.02677071 |
| 114 | Abnormality of the gallbladder (HP:0005264) | 2.01656888 |
| 115 | Hemorrhage of the eye (HP:0011885) | 2.01653305 |
| 116 | Medial flaring of the eyebrow (HP:0010747) | 2.00702100 |
| 117 | Proximal tubulopathy (HP:0000114) | 2.00531534 |
| 118 | Abolished electroretinogram (ERG) (HP:0000550) | 2.00238053 |
| 119 | Dyskinesia (HP:0100660) | 1.97824441 |
| 120 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.97065850 |
| 121 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.94226918 |
| 122 | Rickets (HP:0002748) | 1.92894735 |
| 123 | Genetic anticipation (HP:0003743) | 1.92510097 |
| 124 | Osteomalacia (HP:0002749) | 1.92058696 |
| 125 | Abnormality of iron homeostasis (HP:0011031) | 1.89764701 |
| 126 | Decreased central vision (HP:0007663) | 1.88550069 |
| 127 | Renal cortical cysts (HP:0000803) | 1.88455406 |
| 128 | Increased corneal curvature (HP:0100692) | 1.87459188 |
| 129 | Keratoconus (HP:0000563) | 1.87459188 |
| 130 | Abnormal cartilage morphology (HP:0002763) | 1.87237198 |
| 131 | Hypoplasia of the fovea (HP:0007750) | 1.86811021 |
| 132 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.86811021 |
| 133 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.86783724 |
| 134 | Congenital hepatic fibrosis (HP:0002612) | 1.85608909 |
| 135 | Hypophosphatemic rickets (HP:0004912) | 1.85551918 |
| 136 | Hydroxyprolinuria (HP:0003080) | 1.84821651 |
| 137 | Abnormality of proline metabolism (HP:0010907) | 1.84821651 |
| 138 | Severe visual impairment (HP:0001141) | 1.82942274 |
| 139 | Intestinal atresia (HP:0011100) | 1.80237645 |
| 140 | Elevated hepatic transaminases (HP:0002910) | 1.80046472 |
| 141 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.79974169 |
| 142 | Potter facies (HP:0002009) | 1.79897435 |
| 143 | Facial shape deformation (HP:0011334) | 1.79897435 |
| 144 | Alkalosis (HP:0001948) | 1.78739668 |
| 145 | Abnormality of vitamin metabolism (HP:0100508) | 1.77893964 |
| 146 | Status epilepticus (HP:0002133) | 1.77812118 |
| 147 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.77370162 |
| 148 | Sclerocornea (HP:0000647) | 1.77015821 |
| 149 | Nephritis (HP:0000123) | 1.76303316 |
| 150 | Reticulocytosis (HP:0001923) | 1.75034334 |
| 151 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.71821156 |
| 152 | Focal seizures (HP:0007359) | 1.71262850 |
| 153 | Absent speech (HP:0001344) | 1.70539653 |
| 154 | Febrile seizures (HP:0002373) | 1.68765836 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.33688587 |
| 2 | SIK1 | 4.62725614 |
| 3 | FGFR4 | 4.55827859 |
| 4 | ERN1 | 4.28622783 |
| 5 | MAP4K2 | 3.24382607 |
| 6 | TAOK3 | 3.01302533 |
| 7 | INSRR | 2.85266441 |
| 8 | ERBB4 | 2.77646518 |
| 9 | ADRBK2 | 2.77367116 |
| 10 | BMPR1B | 2.52014490 |
| 11 | PKN2 | 2.45182712 |
| 12 | NUAK1 | 2.43850314 |
| 13 | WNK3 | 2.39005692 |
| 14 | TRIM28 | 2.35858407 |
| 15 | ACVR1B | 2.35276272 |
| 16 | MAP2K4 | 2.35042270 |
| 17 | MST1R | 2.21549421 |
| 18 | FLT3 | 2.05038007 |
| 19 | CASK | 2.03644504 |
| 20 | MAPK13 | 2.00184177 |
| 21 | PIK3CG | 1.89394648 |
| 22 | MAPK11 | 1.82912521 |
| 23 | TRIB3 | 1.79114151 |
| 24 | TYK2 | 1.72721506 |
| 25 | ZAK | 1.62513321 |
| 26 | EIF2AK3 | 1.60810739 |
| 27 | LATS1 | 1.57241709 |
| 28 | OXSR1 | 1.56157664 |
| 29 | DAPK2 | 1.55482807 |
| 30 | MAP3K4 | 1.54884785 |
| 31 | ABL2 | 1.50556236 |
| 32 | PTK6 | 1.50154886 |
| 33 | MKNK2 | 1.48420034 |
| 34 | NEK9 | 1.41786879 |
| 35 | KDR | 1.36164227 |
| 36 | FRK | 1.34462654 |
| 37 | FGFR2 | 1.31533306 |
| 38 | BCR | 1.27862222 |
| 39 | BRSK2 | 1.27697213 |
| 40 | PAK3 | 1.24571694 |
| 41 | JAK2 | 1.22307812 |
| 42 | CAMKK2 | 1.21307102 |
| 43 | NTRK3 | 1.16200832 |
| 44 | MAP2K3 | 1.15937936 |
| 45 | STK39 | 1.14186576 |
| 46 | MAP3K7 | 1.12812644 |
| 47 | PINK1 | 1.12197664 |
| 48 | NEK1 | 1.12167123 |
| 49 | PRKCE | 1.11195755 |
| 50 | PRKAA2 | 1.09491958 |
| 51 | STK38L | 1.07889346 |
| 52 | GRK6 | 1.07859014 |
| 53 | ERBB3 | 1.06665050 |
| 54 | PDK2 | 1.05960938 |
| 55 | TNK2 | 1.05696479 |
| 56 | TBK1 | 1.02106434 |
| 57 | JAK1 | 1.00756812 |
| 58 | MAPK4 | 0.99948745 |
| 59 | ERBB2 | 0.99219473 |
| 60 | MAP3K14 | 0.98711350 |
| 61 | AKT3 | 0.97396291 |
| 62 | FER | 0.95378440 |
| 63 | MAP3K10 | 0.95169628 |
| 64 | PRKCZ | 0.92346907 |
| 65 | MARK1 | 0.92224174 |
| 66 | WNK4 | 0.91492657 |
| 67 | ADRBK1 | 0.91346435 |
| 68 | TNIK | 0.91070280 |
| 69 | MAP3K3 | 0.89783647 |
| 70 | MUSK | 0.89256655 |
| 71 | CDK6 | 0.88566158 |
| 72 | MET | 0.87621003 |
| 73 | MAP3K11 | 0.83840030 |
| 74 | PLK2 | 0.81679756 |
| 75 | CAMK1G | 0.80936758 |
| 76 | MAP2K6 | 0.78796159 |
| 77 | EPHB1 | 0.78399236 |
| 78 | TIE1 | 0.78373174 |
| 79 | MAPK12 | 0.78173312 |
| 80 | PRKACG | 0.77155028 |
| 81 | MAPK15 | 0.75648074 |
| 82 | MKNK1 | 0.75209363 |
| 83 | MAP2K7 | 0.74924721 |
| 84 | PTK2B | 0.73971988 |
| 85 | CSK | 0.71455672 |
| 86 | RIPK1 | 0.71333960 |
| 87 | EPHA3 | 0.70151749 |
| 88 | IRAK3 | 0.69818898 |
| 89 | CAMK2G | 0.69758650 |
| 90 | WEE1 | 0.69122105 |
| 91 | BLK | 0.68610259 |
| 92 | PLK4 | 0.67957913 |
| 93 | SIK3 | 0.67022516 |
| 94 | GSK3A | 0.66930116 |
| 95 | DYRK1B | 0.65569051 |
| 96 | CAMK1D | 0.65366602 |
| 97 | PRKAA1 | 0.64073507 |
| 98 | TGFBR2 | 0.61792587 |
| 99 | TRPM7 | 0.60668381 |
| 100 | SGK3 | 0.58316690 |
| 101 | TEC | 0.56191564 |
| 102 | CSF1R | 0.55130493 |
| 103 | TGFBR1 | 0.54784275 |
| 104 | PTK2 | 0.54765060 |
| 105 | PRKG1 | 0.54671420 |
| 106 | PNCK | 0.54265861 |
| 107 | MAPK7 | 0.54170513 |
| 108 | IKBKE | 0.54058379 |
| 109 | EPHA4 | 0.53637459 |
| 110 | TAOK2 | 0.53539353 |
| 111 | PRKCQ | 0.52827247 |
| 112 | STK3 | 0.52248400 |
| 113 | PRKACA | 0.51218226 |
| 114 | CSNK1D | 0.50949622 |
| 115 | FGFR3 | 0.50249752 |
| 116 | CAMK2A | 0.50045885 |
| 117 | PDPK1 | 0.49197028 |
| 118 | CSNK1G1 | 0.48049122 |
| 119 | CSNK1A1 | 0.46760055 |
| 120 | CDK4 | 0.46274348 |
| 121 | DYRK2 | 0.45142196 |
| 122 | GRK1 | 0.45043026 |
| 123 | CSNK1A1L | 0.44490231 |
| 124 | MARK3 | 0.44307334 |
| 125 | PBK | 0.44137904 |
| 126 | CDK3 | 0.43724612 |
| 127 | IGF1R | 0.43050523 |
| 128 | MAP3K5 | 0.42885456 |
| 129 | MAP3K13 | 0.42617588 |
| 130 | RET | 0.42365882 |
| 131 | MAP2K1 | 0.42220863 |
| 132 | SGK2 | 0.42070197 |
| 133 | MST4 | 0.41424573 |
| 134 | PRKCG | 0.40060199 |
| 135 | PRKACB | 0.39221013 |
| 136 | NLK | 0.37347994 |
| 137 | PRKCB | 0.36487379 |
| 138 | MAP3K6 | 0.35483940 |
| 139 | PKN1 | 0.34674563 |
| 140 | OBSCN | 0.33315737 |
| 141 | TXK | 0.32943975 |
| 142 | ICK | 0.32605689 |
| 143 | MAPKAPK5 | 0.31659637 |
| 144 | PDK1 | 0.31180715 |
| 145 | EGFR | 0.31073405 |
| 146 | MTOR | 0.30511521 |
| 147 | ATM | 0.29655368 |
| 148 | CAMK4 | 0.29605243 |
| 149 | SGK223 | 0.29265892 |
| 150 | SGK494 | 0.29265892 |
| 151 | CSNK1G2 | 0.29062089 |
| 152 | CAMK1 | 0.28139705 |
| 153 | IRAK2 | 0.28125126 |
| 154 | CSNK1G3 | 0.27107378 |
| 155 | PRKCI | 0.26995895 |
| 156 | PRKCA | 0.26076707 |
| 157 | LATS2 | 0.24565205 |
| 158 | IRAK1 | 0.24066225 |
| 159 | MAP3K1 | 0.22226544 |
| 160 | PDK3 | 0.22186432 |
| 161 | PDK4 | 0.22186432 |
| 162 | MAP2K2 | 0.20736649 |
| 163 | PIK3CA | 0.20501173 |
| 164 | ABL1 | 0.20197177 |
| 165 | BMX | 0.18446148 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.48986125 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.62373571 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.40514910 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.39221166 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.04485160 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.75898355 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.72470211 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.66862811 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.64491870 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.52905349 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47346332 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.37820514 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.27381432 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.18042216 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.14774668 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.06285319 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.99691222 |
| 18 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.97584951 |
| 19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.95766629 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.93034094 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.88252440 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.85711335 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.80840511 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.79592879 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.76801675 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.73595448 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.73548416 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.71919576 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.70642972 |
| 30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.65402041 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.64994509 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.57863406 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.56837564 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.52375927 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.50712087 |
| 36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.47963166 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.44196759 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.37139296 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.35563627 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.34509372 |
| 41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.30826891 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28180439 |
| 43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.24705596 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.19094550 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.18858448 |
| 46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.18696817 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.17322093 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.12882022 |
| 49 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.00833845 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.00087548 |
| 51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.98887422 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.98381999 |
| 53 | Phototransduction_Homo sapiens_hsa04744 | 0.97521258 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.97381876 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.97072924 |
| 56 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.89662436 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87913168 |
| 58 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.85837970 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.82195552 |
| 60 | Lysine degradation_Homo sapiens_hsa00310 | 0.79411020 |
| 61 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.76451337 |
| 62 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.75017745 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70099446 |
| 64 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66790599 |
| 65 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.65971242 |
| 66 | Homologous recombination_Homo sapiens_hsa03440 | 0.65225187 |
| 67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58924893 |
| 68 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.57868632 |
| 69 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52757594 |
| 70 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.51544352 |
| 71 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.48544656 |
| 72 | Nicotine addiction_Homo sapiens_hsa05033 | 0.46687182 |
| 73 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.46446009 |
| 74 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46277699 |
| 75 | Protein export_Homo sapiens_hsa03060 | 0.45364126 |
| 76 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.41848578 |
| 77 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.40891745 |
| 78 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.38591276 |
| 79 | Taste transduction_Homo sapiens_hsa04742 | 0.38019606 |
| 80 | Olfactory transduction_Homo sapiens_hsa04740 | 0.34494805 |
| 81 | Prion diseases_Homo sapiens_hsa05020 | 0.31644439 |
| 82 | GABAergic synapse_Homo sapiens_hsa04727 | 0.28421384 |
| 83 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25477722 |
| 84 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25433713 |
| 85 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23860809 |
| 86 | Mineral absorption_Homo sapiens_hsa04978 | 0.23705036 |
| 87 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.23261497 |
| 88 | Insulin resistance_Homo sapiens_hsa04931 | 0.21544928 |
| 89 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20361396 |
| 90 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.19882502 |
| 91 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.15867143 |
| 92 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14862086 |
| 93 | Morphine addiction_Homo sapiens_hsa05032 | 0.14337119 |
| 94 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.12579490 |
| 95 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.08607963 |
| 96 | Circadian rhythm_Homo sapiens_hsa04710 | 0.08505647 |
| 97 | Basal transcription factors_Homo sapiens_hsa03022 | 0.08420539 |
| 98 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.05197099 |
| 99 | Pertussis_Homo sapiens_hsa05133 | 0.03195637 |
| 100 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.03194375 |
| 101 | Insulin secretion_Homo sapiens_hsa04911 | 0.02095057 |
| 102 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.00880773 |
| 103 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.00536197 |
| 104 | Bladder cancer_Homo sapiens_hsa05219 | -0.2538321 |
| 105 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2525396 |
| 106 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2475862 |
| 107 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2424533 |
| 108 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2325311 |
| 109 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2058178 |
| 110 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1955781 |
| 111 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1927503 |
| 112 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1926127 |
| 113 | Hepatitis C_Homo sapiens_hsa05160 | -0.1872060 |
| 114 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1629161 |
| 115 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1623871 |
| 116 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1607297 |
| 117 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1587745 |
| 118 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1529293 |
| 119 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1330052 |
| 120 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1123483 |
| 121 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0922018 |
| 122 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0767664 |
| 123 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0754198 |
| 124 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0263123 |

